Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03958214 · ClinicalTrials.gov registry record · NA

Promoting Self-Regulation Skills and Healthy Eating Habits in Early Head Start

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
244
Enrollment target

NCT03958214: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT03958214 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 244 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03958214, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
244 participants
Enrollment target

Study Summary

The purpose of this study is to test the effectiveness of a new curriculum on toddlers' self-regulation skills and healthy eating habits. The curriculum is being delivered as part of Early Head Start home visits and compared to the effectiveness of usual practice Early Head Start home visits.

Primary Outcome

Healthy eating habits will be assessed through change in body mass index

Interventions

  • BEHAVIORAL Recipe 4 Success
  • BEHAVIORAL Usual practice Early Head Start

Trial Details

FieldValue
Enrollment Target 244 participants
Start Date 2016-11-08
Est. Completion 2020-01-20
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT03958214 record still lists

NCT03958214 is an interventional study that assigns participants to a tested intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which Recipe 4 Success is the first listed.

NCT03958214 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03958214 about?

NCT03958214 is a clinical study titled "Promoting Self-Regulation Skills and Healthy Eating Habits in Early Head Start". The purpose of this study is to test the effectiveness of a new curriculum on toddlers' self-regulation skills and healthy eating habits. The curriculum is being delivered as part of Early Head Start home visits and compared to the effectiveness of usual practice Early Head Start home visits.

What is the current status of trial NCT03958214?

This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2016-11-08. Estimated completion is 2020-01-20.

What interventions are being tested in trial NCT03958214?

The interventions under investigation include: Recipe 4 Success (BEHAVIORAL), Usual practice Early Head Start (BEHAVIORAL).

Who is sponsoring clinical trial NCT03958214?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03958214's enrollment target sits among peer trials

244 438th of 2000 higher than 1,563 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02227251 · 244 participants · Phase 2

    Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  • NCT04317534 · 244 participants · Phase 2

    Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

  • NCT04683250 · 244 participants · Phase 1

    Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities

  • NCT04686305 · 244 participants · Phase 1

    Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03958214, the US trial registry maintained by the National Library of Medicine. NCT03958214 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.